Sign in to continue:

Saturday, August 1st, 2026

Addentax Group Corp. Announces Private Placement Agreement and Nasdaq Filing – July 2026




Addentax Group Corp. Announces \$3.25 Million Private Placement

Addentax Group Corp. Announces \$3.25 Million Private Placement of Common Stock

Key Highlights

  • Issuer: Addentax Group Corp. (the “Company”)
  • Date of Report: July 30, 2026
  • Type of Transaction: Private Placement of Common Stock
  • Shares Issued: 677,084 shares of common stock, par value \$0.001 per share
  • Purchase Price: \$4.80 per share
  • Gross Proceeds: Approximately \$3.25 million
  • Investors: Mr. Hong Zhihao, Mr. Hong Zhiwang, and Mr. Yip Wai Lun
  • Use of Proceeds: General corporate purposes, including working capital and potential strategic investments
  • Exemption: Shares to be issued under Regulation S (offshore transaction, not to U.S. persons)
  • Restrictive Legends: Shares will bear customary Securities Act restrictive legends

Details of the Private Placement Transaction

On July 30, 2026, Addentax Group Corp., a Nevada corporation, entered into separate private placement agreements with three investors: Mr. Hong Zhihao, Mr. Hong Zhiwang, and Mr. Yip Wai Lun. The Company agreed to issue and sell a total of 677,084 shares of its common stock at a price of \$4.80 per share, raising gross proceeds of approximately \$3.25 million.

  • Breakdown of Share Allocation:
    • Mr. Hong Zhihao: 250,000 shares
    • Mr. Hong Zhiwang: 218,750 shares
    • Mr. Yip Wai Lun: 208,334 shares

The net proceeds from this private placement are intended to be used for general corporate purposes, which may include working capital and potential strategic investments. This infusion of capital strengthens the Company’s balance sheet and may enable it to pursue new growth opportunities.

Regulatory and Compliance Notes

  • The common stock will be issued in reliance upon the exemption from registration provided by Regulation S under the Securities Act of 1933. Each investor has represented that they are not a “U.S. person,” and the issuance is expected to occur in an offshore transaction in accordance with Regulation S.
  • The shares, once issued, will bear restrictive legends, indicating that they have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption.
  • No registration rights are provided to investors for these shares, meaning the Company is not obligated to register these shares for resale under U.S. securities laws.

Material Representations and Warranties

  • The Company confirms that all outstanding shares of capital stock have been duly authorized, validly issued, fully paid, and are non-assessable.
  • The Company represents that the proceeds of the placement will be used for general corporate purposes, and there are no undisclosed material liabilities or adverse changes since January 1, 2026, except as disclosed in SEC filings and the private placement agreement.
  • Investors warrant that they are acquiring shares for investment purposes, not for immediate resale, and are either “qualified institutional buyers” or “accredited investors.”
  • Investors acknowledge that the securities are restricted and cannot be sold except under certain exemptions or an effective registration statement.

Shareholder Impact and Potential Price Sensitivity

  • Dilution: The issuance of 677,084 new shares will dilute existing shareholders’ ownership. However, the capital raise could enhance the Company’s financial flexibility and support strategic initiatives, which may be viewed positively by the market depending on execution.
  • Offshore Investors: The transaction does not involve U.S. persons and is structured to comply with Regulation S, potentially broadening the Company’s international shareholder base.
  • Lock-up/Resale Restrictions: The newly issued shares are subject to restrictions on resale, which may limit immediate liquidity and overhang concerns.
  • Potential Growth Initiatives: The Company’s intention to use proceeds for working capital and strategic investments could signal future growth or acquisitions, which may be price sensitive if specifics are later disclosed.
  • Disclosure Requirements: The Company is obligated to notify investors prior to any share repurchase or similar actions that would affect the investors’ percentage ownership following this placement.
  • Material Adverse Effect: The Company represents that no material adverse events have occurred since January 1, 2026, outside of those disclosed.

Other Noteworthy Provisions

  • PRC Approvals: The Company is required to make necessary filings and obtain relevant consents from the People’s Republic of China (PRC) authorities in connection with this transaction, as applicable.
  • No Material Misstatements: The Company and investors represent that no material facts have been omitted or misstated in the agreement or other related filings.
  • Press Releases: Any public announcement regarding this transaction requires mutual consultation, and the Company cannot name investors without prior written consent, unless legally required.
  • Adjustments: If any corporate actions (stock splits, dividends, recapitalizations, etc.) occur prior to closing, share numbers and prices will be adjusted accordingly.

Conclusion

This private placement of \$3.25 million in equity marks an important capital-raising event for Addentax Group Corp. It provides the Company with additional resources for its general and strategic objectives while introducing new offshore investors to the shareholder base. The transaction is structured to comply with applicable securities regulations and contains various protections and representations for both the Company and investors. Shareholders should monitor future disclosures regarding the use of proceeds and any strategic investments resulting from this capital raise, as these could materially impact the Company’s growth trajectory and share value.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Investors should conduct their own due diligence and consult with their financial advisor before making any investment decisions. The information herein is based on publicly available filings and may be subject to change or update without notice.




View ADDENTAX GROUP CORP. Historical chart here



Kadant Inc. Reports Record Q1 2026 Results with 25% Increase in Bookings and Raises Full-Year Guidance

Kadant Inc. Q1 2026 Earnings: Key Investor Highlights Ka...

Averin Capital Acquisition Corp. Announces Partial Exercise of IPO Over-Allotment, Raising $33.86 Million 1

Averin Capital Acquisition Corp. Announces Partial Exercise ...

AvalonBay Communities, Inc. Files Form 8-K with SEC: Company Details, Stock Information, and Filing Summary

AvalonBay Communities, Inc. 2026 Annual Meeting Results and ...